AUTHOR AND EDITOR INFORMATION

Section 1 of 10  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• MEDICATION
• Follow-up
• Miscellaneous
• References

INTRODUCTION

Section 2 of 10  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• MEDICATION
• Follow-up
• Miscellaneous
• References

Background

Originally described independently by Williams and Beuren in 1961, Williams syndrome (WS) is a rare genetic condition. The clinical manifestations include a distinct facial appearance, cardiovascular anomalies, hypercalcemia, and a characteristic neurodevelopmental and behavioral profile.

Pathophysiology

In virtually all cases of williams syndrome, haploinsufficiency (loss of 1 of 2 copies) due to a deletion at chromosome band 7q11.23 that involves the elastin gene (ELN) is implicated. Most deletions are not detected through standard karyotyping but rather through fluorescent in situ hybridization (FISH) for a 2-Mb deletion.^{1, 2, 3} The size of the deletion can vary.^{4, 5, 6}

Williams syndrome is not solely caused by elastin haploinsufficiency; the deletion involves a region that spans more than 25 genes and, hence, is considered a contiguous gene deletion syndrome.^{4, 7} The cardiovascular and connective tissue pathology, as well as facial dysmorphology, is attributed to the elastin gene haploinsufficiency.^{8, 9}

Other genes under investigation for their role in the cognitive profile of Williams syndrome include LIMK1, GTF1IRD1, and GTF2I.^{10, 11, 12} However, genotype-phenotype correlations with genes other than elastin are not yet fully elucidated.^{13, 7}

Frequency

United States

Williams syndrome occurs in 1 per 20,000 births; cases are largely sporadic.

International

Frequency worldwide is the same as in the United States.

Mortality/Morbidity

Cardiovascular disease accounts for most early mortality associated with Williams syndrome. Overall, unexpected death is rare but is 25- to 100-fold higher than in age-matched control subjects.¹⁴ Factors implicated in sudden death have included supravalvar aortic stenosis (SVAS), severe pulmonary stenosis, and myocardial ischemia secondary to either coronary insufficiency or biventricular outflow tract obstruction with ventricular hypertrophy. Coronary insufficiency appears most likely because of stenosis that results from intimal fibrosis and muscular hypertrophy.

Deaths have been reported after induction of anesthesia for minor surgical procedures, during cardiac catheterization and heart surgery, and with progressive heart failure and respiratory infection.^{15, 14, 16} Sudden deaths with no apparent instigating event have also been reported, with apparent underlying myocardial injury.¹⁵ Patients with a higher risk of sudden death may show signs of myocardial ischemia on electrocardiography (such as ST segment depression). Echocardiography, Holter monitoring, and careful evaluation should be considered before the use of anesthesia, sedation, or both or prior to an invasive procedure. Patients have also presented with syncope related to SVAS who died during diagnostic cardiac catheterization. Calcified valvular aortic stenosis has also been reported but not with sudden death.^{17, 18}

Sigmoid diverticulitis in adults is reported at a higher frequency in the Williams syndrome population than in the general population.¹⁹

Williams syndrome is a multisystem condition with other potential consequences, including mental retardation, motor delay, hearing loss, severe dental disease, ocular problems, progressive joint contractures, and bowel and bladder diverticula.

Race

Williams syndrome is panethnic. The prevalence of particular features may vary among populations; for instance, peripheral pulmonary stenosis is more common than SVAS in the Hong Kong Chinese population,²⁰ and people living in Greece have a lower rate of cardiovascular anomalies.²¹

Sex

The deletion is equally prevalent in males and females. A greater severity and earlier presentation of cardiovascular disease may be observed in males.^{22, 23}

Age

Clinical manifestations of Williams syndrome are evident from birth through adulthood. However, features that may be detected antenatally include the characteristic cardiovascular lesions. In addition, fetal ultrasonography of neonates with Williams syndrome has revealed multicystic dysplastic kidney in addition to the congenital heart lesions.²⁴ Associated findings on prenatal screening that have been reported include an increased fetal nuchal translucency and low maternal serum alpha fetoprotein (MSAFP); however, none of the prenatal findings has been proven to be a diagnostic marker of Williams syndrome.

CLINICAL

Section 3 of 10  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• MEDICATION
• Follow-up
• Miscellaneous
• References

History

The history obtained from caregivers of patients with Williams syndrome varies and reflects the wide phenotypic spectrum observed in the syndrome. The neurodevelopmental profile primarily involves 4 areas: cognitive development, language, auditory function, and visuospatial function.²⁵

• Children with Williams syndrome are described as overly friendly, hyperactive, inattentive, and hypersensitive to loud sounds or certain types of sounds.^{26, 27}
• Intellectual, motor, and language skills are typically delayed. Children with Williams syndrome typically have mild-to-moderate mental retardation, but the range includes severe mental retardation to average intelligence.²⁵ Abilities should be considered on an individual basis due to the wide variability among individuals.²⁸ Impaired motor development is often apparent before age 42 months.²⁹
• Older children have relative strengths in language and auditory memory with significant weaknesses in visual-spatial cognition.
• As many as half of all children with Williams syndrome may exhibit autism spectrum social and communicative deficits.³⁰
• Visual-spatial problems may present as gait apraxia, especially on uneven or sandy surfaces.³¹
• A history of hearing deficits and visual disturbances is possible.
• Adults may have a high rate of emotional and behavioral problems, poor social relationships and anxiety, preoccupations and obsessions, and communication disturbances. Few adults achieve complete independence.^{32, 33, 34}
• In children, a history of increased urinary frequency and daytime wetting is possible.³⁵ A history of renal abnormalities is also possible.
• Children may have a history of postnatal growth delay, including short stature with delayed bone age,³⁶ growth hormone deficiency,³⁷ and decreased insulinlike growth factor–1 (IGF1) levels.^{38, 39}
• A history of hypertension may be noted.
• A history of connective tissue abnormalities, such as abnormal joint mobility, hernias, and diverticula, is possible.

Physical

Phenotypic expression of Williams syndrome widely varies. Virtually all cases have typical facial features that can be recognized even at birth.

• Children with Williams syndrome are generally full-term infants.
• Microcephaly is observed in one third of children,⁴⁰ and postnatal failure to thrive is typical.
• The diagnosis of Williams syndrome should also be considered after an incidental finding of idiopathic hypercalcemia or a characteristic cardiac lesion such as SVAS. Other cardiac lesions in patients with Williams syndrome can include pulmonary stenosis and mitral valve regurgitation.^{32, 23} Arterial hypertension may be present. If the distinct facial features are not evident, consider referral to a practitioner experienced in examining the facial features of Williams syndrome, such as a clinical geneticist or cardiologist experienced in dysmorphology.
• Virtually all children and adults with Williams syndrome have some combination of the following facial features: short upturned nose, flat nasal bridge, long philtrum, flat malar area, wide mouth, full lips, dental malocclusion and widely spaced teeth, micrognathia, stellate irides, and periorbital fullness. The voice may be harsh. Nails tend to be hypoplastic and the skin soft and lax, and the hallices have a valgus deviation. "Elfin facies" is considered a pejorative term, and its use should be discouraged.
• Ocular findings can include strabismus (usually due to esotropia), a stellate iris, cataract, retinal vascular tortuosity, and reduced binocular vision; a case of Reiger anomaly has even been reported.^{41, 42, 22}
• Sensorineural hearing loss can be present and is likely underdiagnosed.⁴³ It can be aggravated by conductive loss due to middle ear effusions.
• Examine patients for signs of precocious puberty.
• Other findings include hyperacusis (despite hearing loss), hoarse voice, joint hyperelasticity, contractures, kyphoscoliosis, and lordosis.
• Monitor for hypertension at every visit.

Causes

A deletion on band 7q11.23 near the elastin gene is identified in virtually all individuals with Williams syndrome. The underlying etiology is believed to be unequal meiotic crossover events that lead to interstitial deletions.^{44, 45} These deletions may result in unbalanced interchromosomal and, to a lesser extent, intrachromosomal rearrangements. Mechanisms whereby chromosomes paired during meiosis may undergo unequal crossover resulting in Williams syndrome have typically been thought to result from an unequal overlap of repetitive Alu sequences flanking the region, resulting in a type of misalignment of the chromosomal regions during a crossover event.⁴⁶ In addition, another mechanism that has recently been shown includes a familial inversion polymorphism in the Williams syndrome region that may predispose to unequal crossover during meiosis.⁴⁷

DIFFERENTIALS

Section 4 of 10  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• MEDICATION
• Follow-up
• Miscellaneous
• References

WORKUP

Section 5 of 10  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• MEDICATION
• Follow-up
• Miscellaneous
• References

Lab Studies

• Fluorescent in situ hybridization (FISH) for the 7q11.23 elastin gene deletion should be performed in patients in whom Williams syndrome is suspected, in addition to a routine chromosomal analysis (karyotype). Testing is routinely performed on peripheral blood leukocytes. FISH testing and karyotype are performed in cytogenetics laboratories. An international list of laboratories offering FISH testing for Williams syndrome is available through GeneTests or the European Directory of DNA Diagnostic Laboratories.
• • A standard karyotype should always be performed since a negative FISH result for Williams syndrome does not exclude the possibility of an underlying chromosomal abnormality, and chromosomal translocation in the region affected by Williams syndrome has been reported.⁴⁸
  • Because atypical cases of Williams syndrome may have other chromosomal rearrangements not detected by the standard FISH test, further studies, such as high-resolution chromosome analysis and testing for ELN gene mutations, should be coordinated through a clinical geneticist.
  • FISH testing and chromosomal analysis in the parents is not routinely indicated, unless either parent has associated physical features or other findings for which Williams syndrome is suspected, a positive family history of Williams syndrome, or other affected children with Williams syndrome.
• Multiplex ligation-dependent probe amplification (MLPA) compares favorably with FISH and may be less time consuming. MLPA kits are not currently certified by the US Food and Drug Administration (FDA) for diagnosis.⁴⁹
• Plasma creatine phosphokinase (CPK) levels may be elevated, but the clinical significance is not clear in incidental cases.²¹ Further studies are needed to see if this may relate to an underlying myopathy.⁵⁰
• Obtain baseline measurements of serum calcium, BUN, and serum creatinine levels. Perform routine urinalysis and obtain spot urine calcium/creatinine ratios. Serum calcium can be checked in suspected cases before genetic confirmation of the diagnosis.
• Obtain baseline thyroid-stimulating hormone (TSH) levels.

Imaging Studies

• Perform baseline echocardiography in all patients diagnosed with Williams syndrome, regardless of cardiac physical examination findings. Approximately one half of all children with Williams syndrome have a significant cardiac lesion.
• Cardiovascular management depends on the specific cardiac lesion present. In addition to ECG and echocardiography, children with SVAS may require cardiac catheterization as part of their presurgical evaluation.
• Perform renal ultrasonography in the initial workup to not only look for anatomic abnormalities but also for nephrolithiasis caused by hypercalcemia. The incidence of renal abnormalities in Williams syndrome is significantly higher than that in the general population.⁵¹ Further management may require referral to a urologist, nephrologist, or both.

Other Tests

• Full neurodevelopmental testing may aid the general practitioner in identifying suspected cases of Williams syndrome and may help tailor schooling and supplemental developmental assistance for children already diagnosed with Williams syndrome.

TREATMENT

Section 6 of 10  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• MEDICATION
• Follow-up
• Miscellaneous
• References

Medical Care

Williams syndrome is a complex multisystem medical condition that requires the attention of multiple health care professionals. A few large tertiary care centers have Williams syndrome clinics, which help organize and coordinate the care of patients with Williams syndrome. Williams Syndrome Associations are available in the United States and Canada and are a valuable resource for both parents and health care professionals.

Tailor specific management of Williams syndrome to the presenting clinical spectrum. Initial care often centers on failure to thrive, hypercalcemia, or repair of the cardiac lesion. School performance, physical therapy, hyperactivity, and the child's eventual role in society are long-term issues that need to be addressed on an ongoing basis. Anticipatory guidance is essential to help parents prepare for future needs of children with Williams syndrome. Anticipatory care guidelines and growth curves for children with Williams syndrome are available through the American Academy of Pediatrics.

• Hypercalcemia is frequently asymptomatic and resolves in the first few years of life but can be lifelong.
• • Signs and symptoms of hypercalcemia, in addition to blood calcium levels, should be periodically monitored throughout life and prior to the administration of any anesthetic or sedative agent and prior to any invasive procedure. Symptomatic hypercalcemia can present with decreased feeding, irritability, and severe colic in infants and may require multidisciplinary management through restriction of calcium, vitamin D intakes (including vitamin formulations), specialized formulas and some patients may require bisphosphonates to control elevated calcium levels.^{52, 53} For more information, see Hypercalcemia.
  • The goal of managing calcium and vitamin D levels is to monitor and achieve levels in the normal range for age at intakes adequate for bone growth. The need for dietary manipulation and medication to control hypercalcemia should be frequently monitored because long-term unrestricted use of a low calcium, low vitamin D formula has been reported to lead to rickets in a patient with Williams syndrome.⁵⁴
  • Nephrocalcinosis and sclerosis of the long bones are occasionally observed.
• Systemic hypertension should be treated when identified. For more information see the eMedicine topic in pediatrics for Hypertension or Neonatal Hypertension.
• Periodically assess visual problems and hearing loss. Middle ear infusions should be periodically performed. Acoustic-visual-behavioral training has been reported to improve symptoms of hyperacusis in an adult.⁵⁵
• Patients with short stature should have a bone age assessment and be referred to an endocrinologist for assessment and management of growth hormone deficiency.
• Monitor for signs of precocious puberty and arrange referrals with an endocrinologist as necessary.⁵⁶
• Feeding difficulties in children are common, and referral to a gastroenterologist should be considered.
• Early involvement of dentist is suggested.

Surgical Care

For cardiac findings in children with Williams syndrome, early involvement with a pediatric cardiologist and cardiothoracic surgeon is essential.

• SVAS is the most frequently observed operable cardiac lesion in Williams syndrome. SVAS may be progressive in some individuals, and life-long cardiac follow-up is recommended.⁵⁷
• Timing of the operative repair depends on the presence of cardiac symptoms, the gradient across the supraaortic obstruction, and whether ischemic changes are noted on a stress test. Peripheral branch pulmonary stenosis usually spontaneously resolves and generally should not be treated with catheter or surgical intervention.
• In general, the degree of supraaortic obstruction in Williams syndrome patients tends to progress over time, whereas peripheral branch pulmonary stenosis improves over time.

Consultations

Williams syndrome requires the attention of multiple health care professionals, depending on the specific phenotypic manifestations. Many large tertiary care centers have Williams syndrome clinics that help organize and coordinate the care of patients with Williams syndrome.

• For cardiac findings in children with Williams syndrome, early involvement of a pediatric cardiologist and cardiothoracic surgeon is essential.
• An anesthesiologist should be consulted prior to administration of anesthetics. Sedation should be administered only by physicians experienced in pediatric procedural sedation.
• Geneticists, dentists, ophthalmologists, orthopedists, physical and occupational therapists, and psychologists all contribute to the care of the patient with Williams syndrome.
• Parents of children with Williams syndrome should be offered genetic counseling to review their recurrence risks and options for prenatal diagnosis. If neither parent is affected with Williams syndrome, the risk of having another affected child with Williams syndrome is usually less than 1%. However, recurrences of Williams syndrome have been reported, even with unaffected parents, because of apparent germline mosaicism.⁵⁸ If one parent is affected with Williams syndrome, the risk for having an affected child is typically 50% because the deletion behaves in an autosomal dominant manner. When of appropriate age, affected children should receive genetic counseling prior to considering having children of their own.
• Women with Williams syndrome who are considering pregnancy or who are pregnant should be referred to a maternal-fetal medicine specialist for close monitoring. In particular, a pregnant woman with Williams syndrome should be monitored for hypertension, hypercalcemia, and cardiovascular and other complications.⁵⁹

MEDICATION

Section 7 of 10  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• MEDICATION
• Follow-up
• Miscellaneous
• References

See Treatment.

FOLLOW-UP

Section 8 of 10  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• MEDICATION
• Follow-up
• Miscellaneous
• References

Further Outpatient Care

• School performance, hyperactivity, and the child's eventual role in society are long-term issues that need to be addressed on an ongoing basis.
• Anticipatory guidance is essential to help parents prepare for future needs of children with Williams syndrome.

Prognosis

• Medical complications may occur, especially related to the cardiovascular system. However, most individuals with Williams syndrome are healthy and lead active full lives.
• Most adults with Williams syndrome are used in various settings and can perform self-care tasks.
• Some adults with Williams syndrome require the daily care of parents or caregivers; however, others may live with less supervision and care.

Patient Education

• Inform parents or caregivers of the Williams Syndrome Association for supporting resources and education. Williams Syndrome Associations are located in the United States and Canada. They provide valuable resources for parents and caregivers. The Williams Syndrome Association can be contacted by phone (248-541-3630) or through the Williams Syndrome Association Web site.

MISCELLANEOUS

Section 9 of 10  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• MEDICATION
• Follow-up
• Miscellaneous
• References

Medical/Legal Pitfalls

• Failure to perform echocardiography or to refer patients to a pediatric cardiologist in the presence of any cardiac history or findings
• Failure to consider risks in a patient with Williams syndrome who is pregnant
• Failure to discuss the options of prenatal care and recurrence risks
• Failure to screen and manage high-risk patients prior to anesthetic and sedation procedures, cardiac catheterization, or surgery

REFERENCES

Section 10 of 10

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• MEDICATION
• Follow-up
• Miscellaneous
• References

1. Ewart AK, Morris CA, Atkinson D, et al. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat Genet. Sep 1993;5(1):11-6. [Medline].
2. Lowery MC, Morris CA, Ewart A, et al. Strong correlation of elastin deletions, detected by FISH, with Williams syndrome: evaluation of 235 patients. Am J Hum Genet. Jul 1995;57(1):49-53. [Medline].
3. Nickerson E, Greenberg F, Keating MT, et al. Deletions of the elastin gene at 7q11.23 occur in approximately 90% of patients with Williams syndrome. Am J Hum Genet. May 1995;56(5):1156-61. [Medline].
4. Urbán Z, Helms C, Fekete G, et al. 7q11.23 deletions in Williams syndrome arise as a consequence of unequal meiotic crossover. Am J Hum Genet. Oct 1996;59(4):958-62. [Medline].
5. Hockenhull EL, Carette MJ, Metcalfe K, et al. A complete physical contig and partial transcript map of the Williams syndrome critical region. Genomics. Jun 1 1999;58(2):138-45. [Medline].
6. Heller R, Rauch A, Luttgen S, et al. Partial deletion of the critical 1.5 Mb interval in Williams-Beuren syndrome. J Med Genet. Aug 2003;40(8):e99. [Medline].
7. Merla G, Ucla C, Guipponi M, Reymond A. Identification of additional transcripts in the Williams-Beuren syndrome critical region. Hum Genet. May 2002;110(5):429-38. [Medline].
8. Mari A, Amati F, Mingarelli R, et al. Analysis of the elastin gene in 60 patients with clinical diagnosis of Williams syndrome. Hum Genet. Oct 1995;96(4):444-8. [Medline].
9. Dridi SM, Ghomrasseni S, Bonnet D, et al. Skin elastic fibers in Williams syndrome. Am J Med Genet. Nov 19 1999;87(2):134-8. [Medline].
10. Frangiskakis JM, Ewart AK, Morris CA, et al. LIM-kinase1 hemizygosity implicated in impaired visuospatial constructive cognition. Cell. Jul 12 1996;86(1):59-69. [Medline].
11. Tassabehji M, Metcalfe K, Fergusson WD, et al. LIM-kinase deleted in Williams syndrome. Nat Genet. Jul 1996;13(3):272-3. [Medline].
12. Hirota H, Matsuoka R, Chen XN, et al. Williams syndrome deficits in visual spatial processing linked to GTF2IRD1 and GTF2I on chromosome 7q11.23. Genet Med. Jul-Aug 2003;5(4):311-21. [Medline].
13. Osborne LR. Williams-Beuren syndrome: unraveling the mysteries of a microdeletion disorder. Mol Genet Metab. May 1999;67(1):1-10. [Medline].
14. Wessel A, Gravenhorst V, Buchhorn R. Risk of sudden death in the Williams-Beuren syndrome. Am J Med Genet A. Jun 15 2004;127(3):234-7. [Medline].
15. Bird LM, Billman GF, Lacro RV, et al. Sudden death in Williams syndrome: report of ten cases. J Pediatr. Dec 1996;129(6):926-31. [Medline].
16. Bragg K, Fedel GM, DiProsperis A. Cardiac arrest under anesthesia in a pediatric patient with Williams syndrome: a case report. AANA J. Aug 2005;73(4):287-93. [Medline].
17. Horowitz PE, Akhtar S, Wulff JA, et al. Coronary artery disease and anesthesia-related death in children with Williams syndrome. J Cardiothorac Vasc Anesth. Dec 2002;16(6):739-41. [Medline].
18. Yetkin U, Bal F, Bayata S, Gurbuz A. Severely calcified valvular aortic stenosis firstly diagnosed in monozygotic male twins with suspected Williams-Beuren syndrome. Jpn Heart J. Sep 2004;45(5):877-83. [Medline].
19. Partsch CJ, Siebert R, Caliebe A, et al. Sigmoid diverticulitis in patients with Williams-Beuren syndrome: relatively high prevalence and high complication rate in young adults with the syndrome. Am J Med Genet A. Aug 15 2005;137(1):52-4. [Medline].
20. Yau EK, Lo IF, Lam ST. Williams-Beuren syndrome in the Hong Kong Chinese population: retrospective study. Hong Kong Med J. Feb 2004;10(1):22-7. [Medline].
21. Amenta S, Sofocleous C, Kolialexi A, et al. Clinical manifestations and molecular investigation of 50 patients with Williams syndrome in the Greek population. Pediatr Res. Jun 2005;57(6):789-95. [Medline].
22. Sadler LS, Pober BR, Grandinetti A, et al. Differences by sex in cardiovascular disease in Williams syndrome. J Pediatr. Dec 2001;139(6):849-53. [Medline].
23. Bruno E, Rossi N, Thuer O, et al. Cardiovascular findings, and clinical course, in patients with Williams syndrome. Cardiol Young. Dec 2003;13(6):532-6. [Medline].
24. Zaghloul N, Hutcheon RG, Tepperberg JH. Visual diagnosis: monozygotic twins who have congenital heart disease and distinctive facial features. Pediatr Rev. Oct 2002;23(10):365-7. [Medline].
25. Mervis CB, Robinson BF, Bertrand J, et al. The Williams syndrome cognitive profile. Brain Cogn. Dec 2000;44(3):604-28. [Medline].
26. Blomberg S, Rosander M, Andersson G. Fears, hyperacusis and musicality in Williams syndrome. Res Dev Disabil. Oct 31 2005;[Medline].
27. Gallo FJ, Klein-Tasman BP, Gaffrey MS, Curran P. Expecting the worst: Observations of reactivity to sound in young children with Williams syndrome. Res Dev Disabil. Nov 16 2007;[Medline].
28. Porter MA, Coltheart M. Cognitive heterogeneity in Williams syndrome. Dev Neuropsychol. 2005;27(2):275-306. [Medline].
29. Tsai SW, Wu SK, Liou YM, Shu SG. Early development in Williams syndrome. Pediatr Int. Apr 2008;50(2):221-4. [Medline].
30. Klein-Tasman BP, Mervis CB, Lord C, Phillips KD. Socio-communicative deficits in young children with Williams syndrome: performance on the Autism Diagnostic Observation Schedule. Child Neuropsychol. Sep 2007;13(5):444-67. [Medline].
31. Withers S. A new clinical sign in Williams syndrome. Arch Dis Child. Jul 1996;75(1):89. [Medline].
32. Einfeld SL, Tonge BJ, Rees VW. Longitudinal course of behavioral and emotional problems in Williams syndrome. Am J Ment Retard. Jan 2001;106(1):73-81. [Medline].
33. Davies M, Udwin O, Howlin P. Adults with Williams syndrome. Preliminary study of social, emotional and behavioural difficulties. Br J Psychiatry. Mar 1998;172:273-6. [Medline].
34. Davies M, Howlin P, Udwin O. Independence and adaptive behavior in adults with Williams syndrome. Am J Med Genet. May 16 1997;70(2):188-95. [Medline].
35. Schulman SL, Zderic S, Kaplan P. Increased prevalence of urinary symptoms and voiding dysfunction in Williams syndrome. J Pediatr. Sep 1996;129(3):466-9. [Medline].
36. Partsch CJ, Dreyer G, Gosch A, et al. Longitudinal evaluation of growth, puberty, and bone maturation in children with Williams syndrome. J Pediatr. Jan 1999;134(1):82-9. [Medline].
37. Spadoni GL, Colloridi V, Finocchi G, et al. Williams syndrome and growth hormone deficiency. J Pediatr. Apr 1983;102(4):640. [Medline].
38. Kuijpers GM, De Vroede M, Knol HE, Jansen M. Growth hormone treatment in a child with Williams-Beuren syndrome: a case report. Eur J Pediatr. Jun 1999;158(6):451-4. [Medline].
39. Xekouki P, Fryssira H, Maniati-Christidi M, et al. Growth hormone deficiency in a child with Williams-Beuren syndrome. The response to growth hormone therapy. J Pediatr Endocrinol Metab. Feb 2005;18(2):205-7. [Medline].
40. Pankau R, Partsch CJ, Neblung A, et al. Head circumference of children with Williams-Beuren syndrome. Am J Med Genet. Sep 1 1994;52(3):285-90. [Medline].
41. Greenberg F, Lewis RA. The Williams syndrome. Spectrum and significance of ocular features. Ophthalmology. Dec 1988;95(12):1608-12. [Medline].
42. Kapp ME, von Noorden GK, Jenkins R. Strabismus in Williams syndrome. Am J Ophthalmol. Mar 1995;119(3):355-60. [Medline].
43. Marler JA, Elfenbein JL, Ryals BM, et al. Sensorineural hearing loss in children and adults with Williams syndrome. Am J Med Genet A. Nov 1 2005;138(4):318-27. [Medline].
44. Dutly F, Schinzel A. Unequal interchromosomal rearrangements may result in elastin gene deletions causing the Williams-Beuren syndrome. Hum Mol Genet. Dec 1996;5(12):1893-8. [Medline].
45. Baumer A, Dutly F, Balmer D, et al. High level of unequal meiotic crossovers at the origin of the 22q11. 2 and 7q11.23 deletions. Hum Mol Genet. May 1998;7(5):887-94. [Medline].
46. Robinson WP, Waslynka J, Bernasconi F, et al. Delineation of 7q11.2 deletions associated with Williams-Beuren syndrome and mapping of a repetitive sequence to within and to either side of the common deletion. Genomics. May 15 1996;34(1):17-23. [Medline].
47. Osborne LR, Li M, Pober B, et al. A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome. Nat Genet. Nov 2001;29(3):321-5. [Medline].
48. von Dadelszen P, Chitayat D, Winsor EJ. De novo 46,XX,t(6;7)(q27;q11;23) associated with severe cardiovascular manifestations characteristic of supravalvular aortic stenosis and Williams syndrome. Am J Med Genet. Feb 14 2000;90(4):270-5. [Medline].
49. van Hagen JM, Eussen HJ, van Schooten R, van Der Geest JN, Lagers-van Haselen GC, Wouters CH, et al. Comparing two diagnostic laboratory tests for Williams syndrome: fluorescent in situ hybridization versus multiplex ligation-dependent probe amplification. Genet Test. Fall 2007;11(3):321-7. [Medline].
50. Voit T, Kramer H, Thomas C. Myopathy in Williams-Beuren syndrome. Eur J Pediatr. May 1991;150(7):521-6. [Medline].
51. Sforzini C, Milani D, Fossali E, et al. Renal tract ultrasonography and calcium homeostasis in Williams-Beuren syndrome. Pediatr Nephrol. Nov 2002;17(11):899-902. [Medline].
52. Cagle AP, Waguespack SG, Buckingham BA, et al. Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate. Pediatrics. Oct 2004;114(4):1091-5. [Medline].
53. Oliveri B, Mastaglia SR, Mautalen C, et al. Long-term control of hypercalcaemia in an infant with williams-Beuren syndrome after a single infusion of biphosphonate (Pamidronate). Acta Paediatr. Jul 2004;93(7):1002-3. [Medline].
54. Mathias RS. Rickets in an infant with Williams syndrome. Pediatr Nephrol. Jun 2000;14(6):489-92. [Medline].
55. Miani C, Passon P, Bracale AM, et al. Treatment of hyperacusis in Williams syndrome with bilateral conductive hearing loss. Eur Arch Otorhinolaryngol. Sep 2001;258(7):341-4. [Medline].
56. Partsch CJ, Japing I, Siebert R, et al. Central precocious puberty in girls with Williams syndrome. J Pediatr. Sep 2002;141(3):441-4. [Medline].
57. Wessel A, Pankau R, Kececioglu D, et al. Three decades of follow-up of aortic and pulmonary vascular lesions in the Williams-Beuren syndrome. Am J Med Genet. Sep 1 1994;52(3):297-301. [Medline].
58. Kara-Mostefa A, Raoul O, Lyonnet S, et al. Recurrent Williams-Beuren syndrome in a sibship suggestive of maternal germ-line mosaicism. Am J Hum Genet. May 1999;64(5):1475-8. [Medline].
59. Mulik VV, Temple KI, Howe DT. Two pregnancies in a woman with Williams syndrome. BJOG. May 2004;111(5):511-2. [Medline].
60. Chodirker BN, Greenberg CR, Giddins NG, et al. Low MSAFP levels and Williams syndrome. Am J Med Genet. Nov 12 1997;72(4):448-50. [Medline].
61. Committee on Genetics. American Academy of Pediatrics: Health care supervision for children with Williams syndrome. Pediatrics. May 2001;107(5):1192-204. [Medline].
62. Eronen M, Peippo M, Hiippala A, et al. Cardiovascular manifestations in 75 patients with Williams syndrome. J Med Genet. Aug 2002;39(8):554-8. [Medline].
63. Greer MK, Brown FR 3rd, Pai GS, et al. Cognitive, adaptive, and behavioral characteristics of Williams syndrome. Am J Med Genet. Sep 19 1997;74(5):521-5. [Medline].
64. Huang L, Sadler L, O'Riordan MA, Robin NH. Delay in diagnosis of Williams syndrome. Clin Pediatr (Phila). May 2002;41(4):257-61. [Medline].
65. Lopez-Rangel E, Maurice M, McGillivray B, Friedman JM. Williams syndrome in adults. Am J Med Genet. Dec 1 1992;44(6):720-9. [Medline].
66. Mack G, Silberbach M. Aortic andpulmonary stenosis. Pediatr Rev. Mar 2000;21(3):79-85. [Medline].
67. Morris CA, Mervis CB, Hobart HH, et al. GTF2I hemizygosity implicated in mental retardation in Williams syndrome:Genotype-phenotype analysis of five families with deletions in theWilliams syndrome region. Am J Med Genet. Nov 15 2003;123A(1):45-59. [Medline].
68. Perez Jurado LA, Peoples R, Kaplan P, et al. Molecular definition of the chromosome 7 deletion in Williams syndrome and parent-of-origin effects on growth. Am J Hum Genet. Oct 1996;59(4):781-92. [Medline].
69. Rae C, Karmiloff-Smith A, Lee MA, et al. Brain biochemistry in Williams syndrome: evidence for a role of the cerebellum in cognition?. Neurology. Jul 1998;51(1):33-40. [Medline].
70. Sadler LS, Olitsky SE, Reynolds JD. Reduced stereoacuity in Williams syndrome. Am J Med Genet. Dec 18 1996;66(3):287-8. [Medline].
71. Stagi S, Bindi G, Neri AS, et al. Thyroid function and morphology in patients affected by Williams syndrome. Clin Endocrinol (Oxf). Oct 2005;63(4):456-60. [Medline].
72. Toomey KE. Medical genetics for the practitioner. Pediatr Rev. May 1996;17(5):163-74. [Medline].

Article Last Updated: Jul 16, 2008